HIV and Hepatitis C Among People Who Inject Drugs in Memphis, Tennessee: an Intersectional Risk Environment Analysis of the Social Determinants of Health

被引:0
|
作者
Flath, Natalie [1 ]
Marr, Jack H. [2 ]
Sizemore, Lindsey [3 ]
Pichon, Latrice C. [4 ]
Brantley, Meredith [5 ]
机构
[1] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway, Baltimore, MD 21205 USA
[2] Tennessee Dept Hlth, Communicable & Environm Dis & Emergency Preparedn, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[3] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[4] Univ Memphis, Sch Publ Hlth, Div Social & Behav Sci, 209 Robison Hall, Memphis, TN 38152 USA
[5] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
关键词
HIV; HCV; Persons who inject drugs; Social determinants of health; Intersectional public health; OPIOID CRISIS; UNITED-STATES; B-VIRUS; BALTIMORE; INFECTION; VULNERABILITY; POPULATIONS; DISPARITIES; IMPACT; AIDS;
D O I
10.1007/s40615-023-01878-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe Southern US is confronting bourgeoning HIV and hepatitis C virus (HCV) epidemics among people who inject drugs (PWID), yet little is known about shared and unique risk factors across the region. We applied an intersectional risk environment framework to understand infectious disease outcomes for sub-groups of PWID that experience multiple axes of social marginalization related to racial and ethnic identity and social and economic vulnerability.MethodsHIV and HCV prevalence was estimated from the first iteration of the CDC's National HIV Behavioral Surveillance respondent driven sample of PWID in Shelby County, Tennessee in 2018. We ran adjusted multinomial models to test main and interaction effects of race/ethnicity and structural factors on the prevalence of a three-level outcome: HIV-only, HCV-only, and no infection.ResultsA total of 564 PWID participated, 558 (99%) completed HIV testing, and 540 (96%) HCV testing. Thirty (5%) were HIV-positive, 224 (40%) HCV-positive, and less than 1% were co-infected. Descriptive differences by race/ethnicity and levels of structural vulnerability for HIV and HCV subpopulations were present; however, there was no evidence for statistical interaction. In the final main effects model, HIV status was positively associated with non-Hispanic Black identity (aRR 4.95, 95% CI 1.19, 20.6), whereas HCV status was associated with non-white identity (aRR 0.11 95% CI 0.07, 0.18). Factors associated with HCV infection were higher scores of structural vulnerability (aRR 2.19 95% CI 1.10, 4.35), and criminal legal involvement (aOR 1.99 95% CI 1.18, 3.37).ConclusionThis is the first study to implement local population-based survey data to evaluate distinctive intersections of ethnic/racial and social factors associated with HIV and HCV status among PWID in the Memphis region. Findings come at an opportune time as harm reduction programs are in development in the South and shed light to the need for socially equitable race conscious resource investment.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 50 条
  • [21] Social network methods for HIV case-finding among people who inject drugs in Tajikistan
    Kan, Maxim
    Garfinkel, Danielle B.
    Samoylova, Olga
    Gray, Robert P.
    Little, Kristen M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [22] Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Robaeys, Geert
    Grebely, Jason
    Mauss, Stefan
    Bruggmann, Philip
    Moussalli, Joseph
    De Gottardi, Andrea
    Swan, Tracy
    Arain, Amber
    Kautz, Achim
    Stoever, Heino
    Wedemeyer, Heiner
    Schaefer, Martin
    Taylor, Lynn
    Backmund, Markus
    Dalgard, Olav
    Prins, Maria
    Dore, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S129 - S137
  • [23] Recommendations for the management of hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 1028 - 1038
  • [24] Barriers to HIV and Hepatitis C care for people who inject drugs in Colombia
    Borda, Juan P.
    Friedman, Hannah L.
    Castano, Guillermo A.
    Rodriguez, Henry A.
    Munoz, Carlos F.
    Tofighi, Babak
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2022, 34 (05): : 633 - 638
  • [25] A new challenge for the Mexican health system: hepatitis C in people who inject drugs
    Magis-Rodriguez, Carlos
    Marin-Navarrete, Rodrigo
    Garcia-Juarez, Ignacio
    SALUD MENTAL, 2019, 42 (04) : 147 - 148
  • [26] Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020
    Perkins, Melissa
    Slevin, Amber
    Strand, Mark A.
    Freisner, Daniel
    PREVENTING CHRONIC DISEASE, 2021, 18 : 1 - 12
  • [27] Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan
    Martinez-Perez, Guillermo Z.
    Nikitin, Danil S.
    Bessonova, Alla
    Fajardo, Emmanuel
    Bessonov, Sergei
    Shilton, Sonjelle
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [28] Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China
    Fang, Kailu
    Wang, Hong-liang
    Lin, Yushi
    Li, Shuwen
    Wu, Jie
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (04) : 1043 - 1055
  • [29] Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique
    Baltazar, Cynthia Sema
    Boothe, Makini
    Kellogg, Timothy
    Ricardo, Paulino
    Sathane, Isabel
    Fazito, Erika
    Raymond, Henry F.
    Temmerman, Marleen
    Luchters, Stanley
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [30] Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique
    Cynthia Semá Baltazar
    Makini Boothe
    Timothy Kellogg
    Paulino Ricardo
    Isabel Sathane
    Erika Fazito
    Henry F. Raymond
    Marleen Temmerman
    Stanley Luchters
    BMC Public Health, 20